RxDoctor Payments Data

Samual Gracey, DPM

Foot & Ankle Surgery · Shepherdsville, KYNPI 1386028066

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,734 of the $18,561 with a category attached, or 63.2%. 38 manufacturers reported payments, led by Stryker at 45.5% of the total. Reporting peaked in 2020 at $5,018 and has fallen 80.2% since, to $994 in 2025.

$18,561in general payments, 2019–2025

Across 468 payments — averaging $39.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$8K
  • Vilex LLC$4K
  • Smith+Nephew$2K
  • Medical Device Business Services, Inc.$740
  • Organogenesis Inc.$669
  • Misonix Inc$642
  • plus $3K from 32 others

What the payments were for

  • Speaking & faculty fees$1471%
  • Travel & lodging$6,28934%
  • Food & beverage$11,73463%
  • Education$3922%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,561 in reported general payments places this provider in the 85th percentile of 141 foot & ankle surgery providers in Kentucky.

See all foot & ankle surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$145,563
Medicare patients
444
Services billed
2,324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin113$1,169
Pregabalin14$715
Ketoconazole27$603
Cephalexin16$286
Ciclopirox11$243
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$120
Meloxicam18$101
Triamcinolone Acetonide22$70
Mupirocin19$50

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Shepherdsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →